2 results about "Intravenous use" patented technology

The utility model relates to an equipment belt structure for an assembled ward. The equipment belt structure comprises a mounting unit, a main body unit, a locking unit, a hook unit and an adjusting unit, the connecting structure has the advantages that after the mounting unit is connected with the wall body, the mounting unit is connected with the main body unit in a clamping mode, traditional punching bolt fixing is replaced, damage to a prefabricated wall body structure is avoided, the integrity of the wall body and the advantages of a fabricated building are reserved, meanwhile, the mounting process is simplified, and the construction efficiency is improved; movement of the main body unit can be limited by the locking unit, loosening and displacement of the equipment belt caused by external force collision are avoided, and use safety is guaranteed. The hook unit is matched with the adjusting unit, so that the limitation that the hanging position of an infusion bottle is fixed is solved. The adjusting unit can flexibly adjust the transverse position of the hook unit according to the actual requirements of patients and the position change of the sickbed, the infusion requirements of different patients are met, and operation of medical staff is facilitated.

The application discloses a kind of oral sustained-release composition of edaravone, preparation method and application.The application provides a kind of pharmaceutical composition, it includes tablet core and coating;The tablet core includes drug-containing layer tablet core and / or boost layer tablet core;The drug-containing layer tablet core includes edaravone pharmaceutical active ingredient and carrier;The carrier is one or more in polymer carrier, osmotic pressure regulator, swelling agent, thickening agent and lubricant;The boost layer tablet core includes one or more in osmotic pressure regulator, swelling agent, colorant and lubricant.The pharmaceutical composition of the application maintains 24 hours sustained-release, oral convenient, blood drug concentration is stable, avoids the method of 2 times intravenous drip in a day, improves patient compliance.In addition, the pharmaceutical composition, prescription and preparation process are simple, easy to industrial production.